44 "National Institutes of Health" positions at University of California, San Francisco in united states in United States
-
research enterprises in the world, ranking number one in National Institute of Health funding for 24 consecutive years. ORAL & MAXILLOFACIAL SURGERY Our laboratory employs a multidisciplinary approach of
-
Institutes of Health (NIH). The Department’s clinical enterprise is based at the 183-bed UCSF Benioff Children’s Hospital (BCH) San Francisco, the 191-bed UCSF Benioff Children’s Hospital Oakland, Mount Zion
-
grants) exceeding $58 million. The Department ranks 21st in the nation among pediatric departments for funding from the National Institutes of Health (NIH). The Department’s clinical enterprise is based
-
the nation among pediatric departments for funding from the National Institutes of Health (NIH). The Department’s clinical enterprise is based at the 183-bed UCSF Benioff Children’s Hospital San Francisco
-
constantly ranked in the top five nationally for “Nephrology.” UCSF School of Medicine and Department of Medicine are ranked #1 in National Institutes of Health (NIH) funding. UCSF is the only school
-
large, National Institutes of Health (NIH) training grant has been continuously funded since 1966. Nearly a quarter of all academic pulmonologists in the United States have trained at UCSF. This combined
-
extramural funding (contracts and grants) exceeding $40 million. The department ranks 17th in the nation among Pediatric departments for funding from the National Institutes of Health. The Department’s
-
Foundation currently has >10 active field trials funded by the National Institutes of Health and the Bill & Melinda Gates Foundation. The position will be based at UCSF’s Mission Bay Campus in San Francisco
-
also examining the effects of the early uterine environment on the precursors of metabolic risk in the offspring. The CRC will support this National Institutes of Health (NIH)-funded Research, performing
-
) is a National Institutes of Health funded international consortium to facilitate the advancement of clinical trials at all phases to determine the safety, toxicity and efficacy of promising tolerogenic